Mao C - Search Results

1

A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits.

Gao L, Yu S, Chen Q, Duan Z, Zhou J, Mao C, Yu D, Zhu W, Nie J, Hou Y. Gao L, et al. Among authors: mao c. Vaccine. 2010 Jun 17;28(28):4445-51. doi: 10.1016/j.vaccine.2010.03.062. Epub 2010 Apr 13. Vaccine. 2010. PMID: 20394720 Free PMC article. Clinical Trial.

2

Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis.

Mao C, Pan H, Chen Q, Wang X, Ye D, Qiu L. Mao C, et al. Mol Biol Rep. 2010 Jan;37(1):191-6. doi: 10.1007/s11033-009-9591-6. Epub 2009 Jun 30. Mol Biol Rep. 2010. PMID: 19565352

3

Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls.

Wu M, Mao C, Chen Q, Cu XW, Zhang WS. Wu M, et al. Among authors: mao c. Mol Biol Rep. 2010 Jan;37(1):339-43. doi: 10.1007/s11033-009-9744-7. Epub 2009 Aug 20. Mol Biol Rep. 2010. PMID: 19693693

4

TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Liao RY, Mao C, Qiu LX, Ding H, Chen Q, Pan HF. Liao RY, et al. Among authors: mao c. Mol Biol Rep. 2010 Oct;37(7):3227-32. doi: 10.1007/s11033-009-9906-7. Epub 2009 Nov 1. Mol Biol Rep. 2010. PMID: 19882361

5

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q. Mao C, et al. J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10. J Cancer Res Clin Oncol. 2010. PMID: 20012093

6

KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies.

Mao C, Qiu LX, Liao RY, Du FB, Ding H, Yang WC, Li J, Chen Q. Mao C, et al. Lung Cancer. 2010 Sep;69(3):272-8. doi: 10.1016/j.lungcan.2009.11.020. Epub 2009 Dec 22. Lung Cancer. 2010. PMID: 20022659

7

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.

Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q. Mao C, et al. Breast Cancer Res Treat. 2010 Jul;122(1):259-65. doi: 10.1007/s10549-009-0695-4. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033766

8

Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls.

Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q. Mao C, et al. Breast Cancer Res Treat. 2010 Jun;121(3):719-25. doi: 10.1007/s10549-009-0650-4. Epub 2009 Nov 22. Breast Cancer Res Treat. 2010. PMID: 20464630

9

BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer.

Mao C, Liao RY, Chen Q. Mao C, et al. J Cancer Res Clin Oncol. 2010 Aug;136(8):1293-4. doi: 10.1007/s00432-010-0922-8. Epub 2010 Jun 1. J Cancer Res Clin Oncol. 2010. PMID: 20514492 No abstract available.

10

BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis.

Mao C, Liao RY, Qiu LX, Wang XW, Ding H, Chen Q. Mao C, et al. Mol Biol Rep. 2011 Apr;38(4):2219-23. doi: 10.1007/s11033-010-0351-4. Epub 2010 Sep 21. Mol Biol Rep. 2011. PMID: 20857202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,912 results

Search Page

Filters